Evgen Pharma (EVG)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

0.78p
   
  • Change Today:
      0.008p
  • 52 Week High: 4.05
  • 52 Week Low: 0.75
  • Currency: UK Pounds
  • Shares Issued: 427.35m
  • Volume: 182,758
  • Market Cap: £3.35m
  • RiskGrade: 304

Evgen Pharma Overview

Evgen is a clinical stage drug development company focused on the development of sulforaphane-based compounds, a new class of pharmaceuticals which are synthesised in a proprietary, well-tolerated, stable formulation.

Key Personnel

CEO: Huw Jones
CFO: Toni Hänninen
Independent Non-Executive Director: Alan Barge
Interim Chairman: Susan (Sue) Foden
Non-Executive Dir:

Contact Details

Address: Liverpool Science Park Innovation Centre 2, 146 Brownlow Hill, Liverpool, Merseyside, United Kingdom , L3 5RF
Website: http://www.evgen.com

Listings

Sector: Pharma and Biotech(LSE)
Index: FTSE AIM All-Share
ISIN: GB00BSVYN304

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Evgen Pharma Market Data

Currency UK Pounds
Share Price 0.78p
Change Today 0.008p
% Change 1.08 %
52 Week High 4.05
52 Week Low 0.75
Volume 182,758
Shares Issued 427.35m
Market Cap £3.35m
RiskGrade 304

Evgen Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
22.11% above the market average22.11% above the market average22.11% above the market average22.11% above the market average22.11% above the market average
84.91% above the sector average84.91% above the sector average84.91% above the sector average84.91% above the sector average84.91% above the sector average
Price Trend
93.47% below the market average93.47% below the market average93.47% below the market average93.47% below the market average93.47% below the market average
78.95% below the sector average78.95% below the sector average78.95% below the sector average78.95% below the sector average78.95% below the sector average
Income Not Available
Growth Not Available

Evgen Pharma Dividends

No dividends found

Trades for 19-Apr-2024

Time Volume / Share Price
11:06 53,000 @ 0.78p
08:00 127,807 @ 0.78p
08:00 1,951 @ 0.76p

Evgen Pharma Key Personnel

CEO Huw Jones
CFO Toni Hänninen

Top of Page